Case studies

Strategic Leadership & Market Access

APAC Market Expansion Generates $80M Revenue Across 5 Countries

First biosimilar launch in competitive oncology market dominated by reference product, physician reluctance, limited commercial infrastructure,

Novel Diagnostic Achieves Medicare Coverage with MCIT Pathway

First biosimilar launch in competitive oncology market dominated by reference product, physician reluctance, limited commercial infrastructure,

Rare Disease Launch Generates $200M with Orphan Drug Strategy

First biosimilar launch in competitive oncology market dominated by reference product, physician reluctance, limited commercial infrastructure,

Biosimilar Launch Captures 15% Market Share in Year One

First biosimilar launch in competitive oncology market dominated by reference product, physician reluctance, limited commercial infrastructure,

Precision Genomics Platform Achieves Payer Coverage in 6 Months

Novel multi‑cancer early detection test with $3,000 price point, no established reimbursement pathway, limited clinical evidence, payer